Cannabis compound tested to curb alcohol urges
NCT ID NCT06845124
Summary
This study is testing whether adding cannabidiol (CBD), a compound from the cannabis plant, to the standard medication naltrexone can better reduce alcohol cravings in people with alcohol dependence. It will involve 150 adults who are already in a treatment program and report strong cravings. Participants will take either a high or low dose of CBD with naltrexone, or a placebo with naltrexone, for 14 days to see which combination is most effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOLISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Central Institute of Mental Health
RECRUITINGMannheim, 68159, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Psychiatric Centre North Baden (PZN)
NOT_YET_RECRUITINGWiesloch, Baden-Wurttemberg, 69168, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.